Top Markets
Coin of the day
TCR2 Therapeutics Inc. TCR2 Therapeutics Inc.

TCR2 Therapeutics Inc.

TCRR
Rang în acțiuni #27038
TCR2 Therapeutics Inc. is a clinical-stage immunotherapy firm focused on... TCR2 Therapeutics Inc. is a clinical-stage immunotherapy firm focused on developing cutting-edge T cell receptor (TCR) therapies for cancer patients. The company's lead investigational treatment, gavo-cel, is a unique mono TCR Fusion Construct T cell (TRuC-T cell) designed to target mesothelin-positive solid tumors. This therapy is currently being evaluated in Phase I/II clinical trials for non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma. Furthermore, TCR2 Therapeutics has concluded preclinical development for TC-510, another TRuC-T cell specifically engineered to target mesothelin on solid tumors. They are also advancing TC-520, a CD70-targeting TRuC-T cell designed with fratricide resistance for treating renal cell carcinoma. Founded in 2015, the company, formerly known as TCR2, Inc. until its name change in November 2016, is headquartered in Cambridge, Massachusetts.
Preț acțiune
$1.48
Ultima sincronizare: 2023-05-31
Capitalizare de piață
$35.54M
Schimbare (1 zi)
-5.73%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează TCR2 Therapeutics Inc. (TCRR)

Categorie

Istoric al prețului acțiunii pentru TCR2 Therapeutics Inc. (TCRR)
Cel mai mare preț de închidere: $1.83 pe 2023-05-01

Cel mai mic preț de închidere: $16.51 pe 2019-02-01
Istoric al prețului acțiunii pentru TCR2 Therapeutics Inc. din 2019 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2023 73.43%
2022 -78.52%
2021 -83.60%
2020 79.84%
2019 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$758.75 6.61%
CH